HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of the lipid A analog, E5531 on fever induced by endotoxin from Escherichia coli.

Abstract
E5531 is a specific lipid A antagonist and is expected to be a drug for the treatment of septic shock. The LAL (limulus amebocyte lysate) activity and pyrogenicity of E5531 were determined. The LAL activity of E5531 is large and confirmed that E5531 had a high affinity to the lipopolysaccharide receptor. The pyrogenic activity of E5531 is weak and the pyrogenic profile of E5531 is different from that of USP (United States Pharmacopoeia) reference standard endotoxin (ETX). E5531 suppressed the pyrogenicity of ETX in rabbits, indicating that E5531 is expected to be useful for the treatment of fever induced by ETX.
AuthorsY Asai, Y Nozu, T Ikeuchi, R Narazaki, K Iwamoto, S Watanabe
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 22 Issue 4 Pg. 432-4 (Apr 1999) ISSN: 0918-6158 [Print] Japan
PMID10328569 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Non-Narcotic
  • Endotoxins
  • Lipid A
  • E 5531
  • endotoxin, Escherichia coli
Topics
  • Analgesics, Non-Narcotic (therapeutic use)
  • Animals
  • Dose-Response Relationship, Drug
  • Endotoxins (pharmacology)
  • Fever (chemically induced, drug therapy)
  • Lipid A (analogs & derivatives, therapeutic use)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: